ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,779, issued on April 14, was assigned to MACROGENICS INC. (Rockville, Md.).
"LAG-3-binding molecules and methods of use thereof" was invented by Ross La Motte-Mohs (Boyds, Md.), Kalpana Shah (Boyds, Md.), Douglas H. Smith (San Mateo, Calif.), Leslie S. Johnson (Rockville, Md.), Paul A. Moore (North Potomac, Md.), Ezio Bonvini (Potomac, Md.) and Scott Koenig (Rockville, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is directed to the anti-LAG-3 antibodies, LAG-3 mAb 1, LAG-3 mAb 2, LAG-3 mAb 4, LAG-3 mAb 5, and LAG-3 mAb 6, and to humanized and chimeric versions of such antibodies. The invention additionally pertains to LA...